Dr. Steven C. Lane, MD

Dr. Lane practices at Signature Healthcare Brockton Hospital in Brockton, Massachusetts, part of Signature Healthcare.

Dr. Lane's NPI, 1346235256, was assigned on September 16, 2005. Dr. Lane graduated from Duke University School Of Medicine in 1996. Dr. Lane holds Rhode Island license MD10944.

Dr. Lane's primary practice is Signature Healthcare Brockton Hospital, at 680 Center Street, Brockton, MA 02302 in Plymouth County. The practice phone is (508) 941-7000.

Dr. Lane's primary practice is Signature Healthcare Brockton Hospital in Brockton, Massachusetts, part of Signature Healthcare. The medical group on file is Signature Healthcare Brockton Hospital. Dmand AI also links Dr. Lane to 4 more medical groups, 3 group practices and clinics, 1 imaging center and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lane practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Lane's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lane is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Lane's licenses on file in 3 states: Rhode Island, Massachusetts and North Carolina.

Dmand AI lists brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Lane treats.

CMS data shows 1,474 Medicare services from Dr. Lane across 14 procedure codes in 2024, for 202 Medicare patients. Medicare paid $114,937 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 202 Medicare patients who saw Dr. Lane in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have cancer, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lane's median patient age at 72, with 43% women.

In 2024, Dr. Lane wrote 127 Medicare Part D claims for 49 patients. 98% of them were for generic drugs. CMS names the drug for 81 of them, across 3 drugs with 11 or more claims each, at $1,758 in total drug cost. In 2023, CMS named 92 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lane for performance year 2024, reported individually. Dr. Lane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Lane, published from 2010 to 2012. 2011 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cells and Leukemia, Myeloid, Acute. Dr. Lane's most frequent co-authors are John Paul Thropay, MD, James C. Wurzer, MD and Harish Gangaram Ahuja, MD.

CMS Open Payments shows 7 general payments to Dr. Lane from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Focal Therapeutics, Inc. paid the most, $118.

Dr. Lane graduated from Duke University School Of Medicine in 1996.

Dr. Lane is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.